Going back over the last 25 years, historically, McMaster's reactor has been self-supporting. We manufacture medical isotopes and do irradiation services, so the reactor itself has been largely self-sustaining.
There have been recent investments for us to do a one-time increase of our radioisotope production and increase hours of operation, but in terms of sustained funding, it is a struggle for the reactor on a yearly basis to make sure that it's at least a cost-neutral revenue centre within the university.
